Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The lymphocyte-to-monocyte ratio as a significant inflamm... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy
0
Authors
Kazuyuki Numakura
16 more
Kazuyuki Numakura
•
Yuya Sekine
14 more
•
Tomonori Habuchi
Published
May 26, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
International Journal of Clinical Oncology
Topics
Medicine
Cancer Oncology
Epidemiology
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1007/s10147-024-02538-8
